(-)-ROELACTAMINE;(-)-11,12-DIHYDRO-14-METHYL-11,5-(IMINOMETHANO)-5H-CYCLOHEPTA-[1,2-F:4,5-F']-BIS-[1,3]-BENZODIOXOL-15-ONE
Compound with spectra: 1 NMR
![(-)-ROELACTAMINE;(-)-11,12-DIHYDRO-14-METHYL-11,5-(IMINOMETHANO)-5H-CYCLOHEPTA-[1,2-F:4,5-F']-BIS-[1,3]-BENZODIOXOL-15-ONE](/api/compound/8HMx8VP8t13.png?ph=true&h=300&w=458 "(-)-ROELACTAMINE;(-)-11,12-DIHYDRO-14-METHYL-11,5-(IMINOMETHANO)-5H-CYCLOHEPTA-[1,2-F:4,5-F']-BIS-[1,3]-BENZODIOXOL-15-ONE")
| SpectraBase Compound ID | 8HMx8VP8t13 |
|---|---|
| InChI | InChI=1S/C19H15NO5/c1-20-13-2-9-3-14-15(23-7-22-14)4-10(9)18(19(20)21)12-6-17-16(5-11(12)13)24-8-25-17/h3-6,13,18H,2,7-8H2,1H3/t13-,18+/m0/s1 |
| InChIKey | FSNBUNXHIRYQOB-SCLBCKFNSA-N |
| Mol Weight | 337.33 g/mol |
| Molecular Formula | C19H15NO5 |
| Exact Mass | 337.095023 g/mol |
| Enantiomer InChIKey | FSNBUNXHIRYQOB-ACJLOTCBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
13-Oxothalidine
(-)-(5R,11S,14R)-REFAMIDINE-N-OXIDE;(-)-(5R,11S,14R)-11,12-DIHYDRO-14-METHYL-11,5-(IMINOMETHANO)-5H-CYCLOHEPTA-[1,2-F:4,5-F']-BIS-[1,3]-BENZODIOXOLE-14-OXIDE
10-Acetoxycaryachine
(2S,4S,11bR)-9,10-dimethoxy-2,4-diphenyl-2,6,7,11b-tetrahydro-1H-[1,3,2]oxazaphosphinino[4,3-a]isoquinoline 4-oxide
N-Cyclohexyl-4,5-dihydro-5-(2,4,6-trinitrophenyl)-1,2,3-triazolo[1,5-a][1,4]benzodiazepine-6-carboxamide
CNNBBJDBNJIMFL-DSBRWUDFSA-N
2-Nor-Isotetrandrine
2-N-NORTETRANDRINE
5H-Isoxazolo[2,3-a]pyrazine-2,3-dicarboxylic acid, 4,4-diethyl-3a,4,6,7-tetrahydro-3a-methyl-6-oxo-, dimethyl ester
3H-naphtho[1,2,3-de]quinoline-2,7-dione, 1-(cyclohexylamino)-3-methyl-
| Title | Journal or Book | Year |
|---|---|---|
| Epimeric IsopavineN-Oxides fromRoemeria refracta | Helvetica Chimica Acta | 1992 |